Paul J. Greaves

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Can health inequalities in sickle cell disease be addressed through novel therapies?

Can health inequalities in sickle cell disease be addressed through novel therapies?

Journal: HemaSphere

Published: May 21, 2025

Tocilizumab provides a potential therapeutic option for the management of hyperhaemolysis syndrome in sickle cell disease: A case series and brief narrative overview of the literature.

Tocilizumab provides a potential therapeutic option for the management of hyperhaemolysis syndrome in sickle cell disease: A case series and brief narrative overview of the literature.

Journal: Transfusion medicine (Oxford, England)

Published: May 09, 2025

Exploring The Cognition Room.

Exploring The Cognition Room.

Journal: British journal of nursing (Mark Allen Publishing)

Published: January 25, 2024

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.

Journal: Blood advances

Published: August 15, 2023

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications.

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications.

Journal: Blood cancer journal

Published: February 19, 2023

Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.

Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.

Journal: British journal of haematology

Published: November 06, 2022

Management of secondary central nervous system lymphoma.

Management of secondary central nervous system lymphoma.

Journal: British journal of haematology

Published: August 13, 2022

A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial.

A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial.

Journal: British journal of haematology

Published: January 29, 2021

Outcomes sensitive to critical care nurse staffing levels: A systematic review.

Outcomes sensitive to critical care nurse staffing levels: A systematic review.

Journal: Intensive & critical care nursing

Published: January 25, 2021

Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion.

Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion.

Journal: Clinical case reports

Published: February 08, 2016

Sweet syndrome as terminal event in ruxolitinib-treated myelofibrosis.

Sweet syndrome as terminal event in ruxolitinib-treated myelofibrosis.

Journal: British journal of haematology

Published: February 25, 2015

Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Journal: Haematologica

Published: November 27, 2014

Showing 1-12 of 25

Last Updated: 09/26/2026